We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$384M
AUM Growth
+$42.1M
Cap. Flow
+$6.1M
Cap. Flow %
1.59%
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$1.7M
2
NVDA icon
NVIDIA
NVDA
+$477K
3
ET icon
Energy Transfer Partners
ET
+$408K
4
IBM icon
IBM
IBM
+$398K
5
MCD icon
McDonald's
MCD
+$344K

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 14.79%
3 Consumer Staples 13.71%
4 Miscellaneous 12.81%
5 Financials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.8M 0.47%
7,784
-40
-0.5% -$8.81K
NVO
52
Novo Nordisk
NVO
$202B
$1.78M 0.46%
50,936
-450
-0.9% -$15.6K
BIIB icon
53
Biogen
BIIB
$32.3B
$1.66M 0.43%
6,791
-100
-1% -$25.8K
BMY icon
54
Bristol-Myers Squibb
BMY
$136B
$1.56M 0.41%
25,132
+150
+0.6% +$9.22K
LQD icon
55
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.56M 0.41%
+11,270
New +$1.53M
FAST icon
56
Fastenal
FAST
$57.1B
$1.53M 0.4%
62,820
TCBIP
57
DELISTED
Texas Capital Bancshares, Inc. Non Cumulative Preferred Perpetual Stock Series A
TCBIP
$1.46M 0.38%
56,953
-700
-1% -$18K
HRL icon
58
Hormel Foods
HRL
$11.9B
$1.44M 0.38%
30,980
-700
-2% -$34.2K
MAR icon
59
Marriott International
MAR
$91.5B
$1.44M 0.37%
10,891
TMO icon
60
Thermo Fisher Scientific
TMO
$230B
$1.4M 0.36%
3,006
+48
+2% +$22.5K
PFE icon
61
Pfizer
PFE
$159B
$1.35M 0.35%
36,727
-1,878
-5% -$68.9K
IPGP icon
62
IPG Photonics
IPGP
$3.26B
$1.32M 0.34%
5,920
AMGN icon
63
Amgen
AMGN
$234B
$1.1M 0.29%
4,790
+125
+3% +$28.8K
FBIN icon
64
Fortune Brands Innovations
FBIN
$5.43B
$1.07M 0.28%
14,668
ET icon
65
Energy Transfer Partners
ET
$73.4B
$1.07M 0.28%
173,714
-67,496
-28% -$408K
VZ icon
66
Verizon
VZ
$208B
$1.07M 0.28%
+18,138
New +$1.08M
WFC.PRX
67
DELISTED
Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu
WFC.PRX
$986K 0.26%
37,575
-425
-1% -$11K
FLO icon
68
Flowers Foods
FLO
$1.51B
$947K 0.25%
41,827
BAC icon
69
Bank of America
BAC
$436B
$918K 0.24%
30,284
-2,289
-7% -$61.4K
XBI icon
70
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$902K 0.23%
6,408
DUK icon
71
Duke Energy
DUK
$93.8B
$847K 0.22%
9,253
BNY
72
Bank of New York Mellon
BNY
$110B
$777K 0.2%
18,318
USB icon
73
US Bancorp
USB
$97.3B
$756K 0.2%
16,217
+458
+3% +$19.4K
WTFCP
74
DELISTED
Wintrust Financial Corporation Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E
WTFCP
$698K 0.18%
24,516
+6,150
+33% +$169K
DE icon
75
Deere & Co
DE
$170B
$677K 0.18%
2,516
-200
-7% -$49.7K

Similar funds

American Research & Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
  • American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
  • American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
  • American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
  • American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
  • American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
  • American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.

Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.